Company intelligence / Profile preview

Vimian Group AB

Stockholm, Sweden

Ownership: Private
Employees: ~1200
Development stage: Other

Overview

Vimian is a commercial, global animal health group integrating specialty pharmaceuticals, MedTech (orthopaedic implants and related devices), veterinary buying-group/services and molecular/immunodiagnostics; it grows through organic R&D and acquisitions and reports several hundred million EUR in annual revenue[2][4][5].

Modalities: Small moleculeBiologicDeviceDiagnostic
Industry: Veterinary

Partnerships

Evonik (poultry diagnostic solutions and salmonella typing tests)[4]AI partners for parasite analysis and diagnosis in veterinary diagnostics (partner name not specified)[4]

Beyond the preview

Go deeper on Vimian Group AB.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Vimian Group AB.

Explore the full profile